| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 5 |
| 1 | ASPIRIN 325 MG | 5 |
| 2 | ASPIRIN 81 MG | 5 |
| 3 | ALEMTUZUMAB | 3 |
| 4 | AMBRISENTAN | 3 |
| 5 | EVOLOCUMAB | 3 |
| 6 | MACITENTAN | 3 |
| 7 | OMEPRAZOLE MAGNESIUM | 3 |
| 8 | AMLODIPINE BESYLATE | 2 |
| 9 | ATORVASTATIN CALCIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 1 | NISOLDIPINE | 1 | 0.0008 |
| 2 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 3 | MOMELOTINIB | 1 | 0.0007 |
| 4 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 5 | MARIBAVIR | 1 | 0.0004 |
| 6 | ISAVUCONAZONIUM SULFATE | 1 | 0.0003 |
| 7 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 8 | LARONIDASE | 1 | 0.0002 |
| 9 | VERAPAMIL HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 3 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 7 | Anti-anginal [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |